These TILs were associated with the generation of pro-inflammatory cytokines, such as interleukin-2 (IL-2), tumor necrosis factor-α (TNF-α), and interferon-gamma (IFN-γ), suggesting metformin’s effect for activating anti-tumor immune responses [93]. The gene discussed is IFNG; the disease is neoplasm.